These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 30698524)
21. Medical abortion in Nepal: a qualitative study on women's experiences at safe abortion services and pharmacies. Rogers C; Sapkota S; Paudel R; Dantas JAR Reprod Health; 2019 Jul; 16(1):105. PubMed ID: 31307474 [TBL] [Abstract][Full Text] [Related]
22. Predictors of prior unsuccessful pharmacy abortion attempts among women presenting for abortion in government certified clinics in Nepal. Ahlbach C; Puri MC; Daniel S; Rocca CH; Karki S; Foster DG Int J Gynaecol Obstet; 2022 Oct; 159(1):160-165. PubMed ID: 35152426 [TBL] [Abstract][Full Text] [Related]
23. Women's experiences with the use of medical abortion in a legally restricted context: the case of Argentina. Ramos S; Romero M; Aizenberg L Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):4-15. PubMed ID: 25702064 [TBL] [Abstract][Full Text] [Related]
24. Knowledge, provision of information and barriers to high quality medication abortion provision by pharmacists in Uttar Pradesh, India. Diamond-Smith N; Percher J; Saxena M; Dwivedi P; Srivastava A BMC Health Serv Res; 2019 Jul; 19(1):476. PubMed ID: 31296200 [TBL] [Abstract][Full Text] [Related]
25. Pharmacy access to medical abortion from trained providers and post-abortion contraception in Nepal. Puri MC; Harper CC; Maharjan D; Blum M; Rocca CH Int J Gynaecol Obstet; 2018 Nov; 143(2):211-216. PubMed ID: 29992555 [TBL] [Abstract][Full Text] [Related]
26. Gestational dating using last menstrual period and bimanual exam for medication abortion in pharmacies and health centers in Nepal. Averbach S; Puri M; Blum M; Rocca C Contraception; 2018 Oct; 98(4):296-300. PubMed ID: 29936150 [TBL] [Abstract][Full Text] [Related]
27. Treading the Thin Line: Pharmacy Workers' Perspectives on Medication Abortion Provision in Lusaka, Zambia. Footman K; Chelwa N; Douthwaite M; Mdala J; Mulenga D; Brander C; Church K Stud Fam Plann; 2021 Jun; 52(2):179-194. PubMed ID: 33826147 [TBL] [Abstract][Full Text] [Related]
28. Acceptability and feasibility of medical abortion in Nepal. Karki C; Pokharel H; Kushwaha A; Manandhar D; Bracken H; Winikoff B Int J Gynaecol Obstet; 2009 Jul; 106(1):39-42. PubMed ID: 19345944 [TBL] [Abstract][Full Text] [Related]
29. The role of auxiliary nurse-midwives and community health volunteers in expanding access to medical abortion in rural Nepal. Puri M; Tamang A; Shrestha P; Joshi D Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):94-103. PubMed ID: 25702073 [TBL] [Abstract][Full Text] [Related]
30. Expanding access to medication abortion through pharmacy dispensing of mifepristone: Primary care perspectives from Illinois. Rasmussen KN; Janiak E; Cottrill AA; Stulberg DB Contraception; 2021 Jul; 104(1):98-103. PubMed ID: 33781760 [TBL] [Abstract][Full Text] [Related]
31. Providers' perspectives on denial of abortion care in Nepal: a cross sectional study. Puri MC; Raifman S; Khanal B; Maharjan DC; Foster DG Reprod Health; 2018 Oct; 15(1):170. PubMed ID: 30305079 [TBL] [Abstract][Full Text] [Related]
32. Expansion of Safe Abortion Services in Nepal Through Auxiliary Nurse-Midwife Provision of Medical Abortion, 2011-2013. Andersen KL; Basnett I; Shrestha DR; Shrestha MK; Shah M; Aryal S J Midwifery Womens Health; 2016; 61(2):177-84. PubMed ID: 26860072 [TBL] [Abstract][Full Text] [Related]
33. Abortion in Nepal: perspectives of a cross-section of sexual and reproductive health and rights professionals. Rogers C; Sapkota S; Tako A; Dantas JAR BMC Womens Health; 2019 Feb; 19(1):40. PubMed ID: 30808340 [TBL] [Abstract][Full Text] [Related]
34. Implementation considerations when expanding health worker roles to include safe abortion care: a five-country case study synthesis. Glenton C; Sorhaindo AM; Ganatra B; Lewin S BMC Public Health; 2017 Sep; 17(1):730. PubMed ID: 28934942 [TBL] [Abstract][Full Text] [Related]
35. Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project. LaRoche KJ; Wylie A; Persaud M; Foster AM Contraception; 2022 May; 109():37-42. PubMed ID: 35031301 [TBL] [Abstract][Full Text] [Related]
36. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland. Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039 [TBL] [Abstract][Full Text] [Related]
37. Availability and provision of misoprostol and other medicines for menstrual regulation among pharmacies in Bangladesh via mystery client survey. Huda FA; Ngo TD; Ahmed A; Alam A; Reichenbach L Int J Gynaecol Obstet; 2014 Feb; 124(2):164-8. PubMed ID: 24268354 [TBL] [Abstract][Full Text] [Related]
38. Medication abortion: Potential for improved patient access through pharmacies. Raifman S; Orlando M; Rafie S; Grossman D J Am Pharm Assoc (2003); 2018; 58(4):377-381. PubMed ID: 29752204 [TBL] [Abstract][Full Text] [Related]
39. Medical termination of pregnancy in general practice in Australia: a descriptive-interpretive qualitative study. Dawson AJ; Nicolls R; Bateson D; Doab A; Estoesta J; Brassil A; Sullivan EA Reprod Health; 2017 Mar; 14(1):39. PubMed ID: 28288649 [TBL] [Abstract][Full Text] [Related]
40. A qualitative analysis of pharmacists' attitudes towards provision of medication abortion. Sandoval S; Chen G; Rafie S; Rabin B; Mody S; Averbach S BMC Health Serv Res; 2023 May; 23(1):557. PubMed ID: 37254171 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]